Apple at $3.5 Trillion: Innovation, Loyalty, or Just Buybacks?
Apple’s valuation now rests on a delicate balance between financialization and its ability to monetize loyalty.
BTC$63,649.00+1.27%
ETH$1,666.20+0.82%
USDT$0.9994+0.08%
USDC$0.9998+0.03%
XRP$1.13+0.57%
SOL$66.88+1.42%
TRX$0.3154+0.82%
FIGR_HELOC$1.03+0.07%
DOGE$0.0864+1.38%
HYPE$58.28+2.33%
USDS$0.9997+0.00%
LEO$9.56-0.55%
RAIN$0.013-0.97%
ZEC$412.41-1.07%
XMR$340.72-11.83%
BTC$63,649.00+1.27%
ETH$1,666.20+0.82%
USDT$0.9994+0.08%
USDC$0.9998+0.03%
XRP$1.13+0.57%
SOL$66.88+1.42%
TRX$0.3154+0.82%
FIGR_HELOC$1.03+0.07%
DOGE$0.0864+1.38%
HYPE$58.28+2.33%
USDS$0.9997+0.00%
LEO$9.56-0.55%
RAIN$0.013-0.97%
ZEC$412.41-1.07%
XMR$340.72-11.83%
With fewer legacy constraints than its US counterpart, China’s tech sector is positioned for accelerated expansion.
Apple’s valuation now rests on a delicate balance between financialization and its ability to monetize loyalty.
From tariffs to jobs data, U.S. macro trends are tightening the Fed’s bind, fueling gold’s appeal as a safe-haven hedge against the manipulated dollar.
With LLMs diagnosing and robots operating, the future of medicine is unfolding, and investors can buy in now.
Palantir’s $372.6 billion valuation rests on a price-to-earnings ratio over 15 times higher than Amazon’s.
With Europe reeling from trade headwinds, America’s luxury labels are quietly stealing the spotlight.
TeraWulf’s pivot into AI and HPC hosting, backed by Google’s investment, positions it at the intersection of Bitcoin scarcity and the AI compute boom.
Gold’s dual role as an inflation hedge and economic safety net positions leading miners like Franco-Nevada, Barrick, and Newmont for continued upside
Lower ad spend from a key DSP partner sent PubMatic’s stock reeling, even as the company doubles down on CTV and AI-driven monetization.
Palantir’s role in U.S. public-private governance has never been clearer, and PLTR stock is moving in lockstep.
So far, Apple’s AI strategy appears underfunded by contrast with the Big Tech cluster. Simultaneously, it is difficult to ignore AI’s underlying problems.
ARM Holdings shares crashed over 11% on Thursday after the chip designer provided weak Q2 earnings guidance and hinted at developing its own processors.
Ozempic-famed Novo Nordisk took over a $70 billion wipeout off its market value this week. Is this the beginning of a trend, or a great opportunity?